Profiling Heterogeneous Circulating Tumor Cells (CTC) Populations in Pancreatic Cancer Using a Serial Microfluidic CTC Carpet Chip
Authors:
- 26 September 2018
- journal article
- research article
- Published by Wiley in Advanced Biosystems
- Vol. 2 (12)
Abstract
Although isolation of circulating tumor cells (CTCs) from pancreatic adenocarcinoma patients is feasible, investigating their clinical utility has proven less successful than other cancers due to the limitations of epithelial cellular adhesion molecule (EpCAM)‐only based CTC assays. An integrated technology‐ and biology‐based approach using a microfluidic “Carpet Chip” is presented to study the biological relevance of heterogeneous CTC populations. Both epithelial CTCs (EpCs) and epithelial‐to‐mesenchymal transition (EMT)‐like CTCs (EMTCs) are isolated simultaneously from the whole blood of pancreatic cancer (PaCa) patients (n = 35) by separately targeting two surface markers: EpCAM and CD133. Recovery of cancer cell lines spiked into whole blood is ≥97% with >76% purity. Thirty‐four patients had ≥5 EpCs mL−1 and 35 patients had ≥15 EMTCs mL−1. Overall, significantly higher numbers of EMTCs than EpCs are recovered, reflecting the aggressive nature of PaCa. Furthermore, higher numbers of EMTCs are observed in patients with lymph node involvement compared to patients without. Gene expression profiling of CTCs from 17 patients reveals that CXCR1 is significantly upregulated in EpCs, while known stem cell markers POU5F1/Oct‐4 and MYC are upregulated in EMTCs. In conclusion, successful isolation and genomic profiling of heterogeneous CTC populations are demonstrated, revealing genetic signatures relevant to patient outcomes.Keywords
Funding Information
- National Institutes of Health (1DP2OD006672‐01)
- U.S. Department of War
- University of Michigan Comprehensive Cancer Center (P30CA046592)
This publication has 31 references indexed in Scilit:
- Circulating tumor cells as a biomarker of response to treatment in patient derived xenograft mouse models of pancreatic adenocarcinomaJournal of the American College of Surgeons, 2013
- Single‐cell analysis of circulating tumor cells identifies cumulative expression patterns of EMT‐related genes in metastatic prostate cancerThe Prostate, 2012
- Plasticity of disseminating cancer cells in patients with epithelial malignanciesCancer and Metastasis Reviews, 2012
- The dynamics of cancer stem cellsNeoplasma, 2012
- EMT and Dissemination Precede Pancreatic Tumor FormationCell, 2012
- Vimentin in cancer and its potential as a molecular target for cancer therapyCellular and Molecular Life Sciences, 2011
- Significance of CD133 as a cancer stem cell markers focusing on the tumorigenicity of pancreatic cancer cell linesJournal of the Korean Surgical Society, 2011
- Isolation of circulating tumor cells using a microvortex-generating herringbone-chipProceedings of the National Academy of Sciences, 2010
- Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary resultJournal of Hepato-Biliary-Pancreatic Surgery, 2008
- Isolation of rare circulating tumour cells in cancer patients by microchip technologyNature, 2007